Daniel O’Day is likely to joint Gilead Sciences sometime in 2019; a formal date has not been set. According to a source familiar with the matter at hand, Gilead Sciences Inc, a drugmaker, will appoint Roche Holding AG’s Daniel O’Day… Read More ›